The Impact Of Inadequate Response To Prior Biologic Agents On Abatacept Drug Retention In Rheumatoid Arthritis Patients. A Pan-European Analysis Of RA Registries

被引：0
|
作者：
Finckh, Axel [1 ]
Iannone, Florenzo [2 ]
Gomez Reino, Juan [3 ]
Neto, David [1 ]
Lie, Elisabeth [4 ]
van Riel, Piet [5 ]
Hetland, Merete Lund [6 ]
Pavelka, Karel [7 ]
Turesson, Carl [8 ]
Mariette, Xavier [9 ]
Gottenberg, Jacques-Eric [10 ]
机构：
[1] Univ Geneva, Geneva, Switzerland
[2] Univ Bari, Rheumatol Unit, DIMIMP, Bari, Italy
[3] Hosp Clin Santiago, Santiago De Compostela, Spain
[4] Diakonhjemmet Hosp, Oslo, Norway
[5] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[6] Glostrup Cty Hosp, Danish Rheumatol Database DANBIO, Copenhagen, Denmark
[7] Charles Univ Prague, Dept Clin & Expt Rheumatol, Prague, Czech Republic
[8] Lund Univ, Malmo, Sweden
[9] Bicetre Univ Hosp, Le Kremlin Bicetre, France
[10] Strasbourg Univ Hosp, Strasbourg, France
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
495
引用
收藏
页码：S217 / S217
页数：1
相关论文
共 50 条
  • [21] The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review
    Moots, Robert J.
    Naisbett-Groet, Barbara
    RHEUMATOLOGY, 2012, 51 (12) : 2252 - 2261
  • [22] IMPACT OF GENDER ON THE RESPONSE AND THE TOLERANCE TO TREATMENT WITH ABATACEPT IN RA PATIENTS: RESULTS FROM THE "ORENCIA AND RHEUMATOID ARTHRITIS" REGISTRY
    Nourisson, C.
    Gottenberg, J. -E.
    Mariette, X.
    Mulliez, A.
    Bardin, T.
    Cantagrel, A.
    Combe, B.
    Dougados, M.
    Flipo, R. -M.
    Gaudin, P.
    Vittecoq, O.
    Schaeverbeke, T.
    Sibilia, J.
    Soubrier, M.
    Ravaud, P.
    Tournadre, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1043 - 1043
  • [23] Monitoring Drug and Antidrug Levels: A Rational Approach in Rheumatoid Arthritis Patients Treated with Biologic Agents Who Experience Inadequate Response While Being on a Stable Biologic Treatment
    Mazilu, Diana
    Opris, Daniela
    Gainaru, Cecilia
    Iliuta, Mihaela
    Apetrei, Natalia
    Luca, Giorgiana
    Borangiu, Andreea
    Gudu, Tania
    Peltea, Alexandra
    Groseanu, Laura
    Constantinescu, Cosmin
    Saulescu, Ioana
    Bojinca, Violeta
    Balanescu, Andra
    Predeteanu, Denisa
    Ionescu, Ruxandra
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [24] OBESE PATIENTS WITH RHEUMATOID ARTHRITIS HAVE REDUCED RESPONSE RATES TO BIOLOGIC ANTI-RHEUMATIC AGENTS: A COMPARISON BETWEEN EUROPEAN AND AMERICAN RA PATIENTS
    Finckh, A.
    Scherer, A.
    Kremer, J.
    Greenberg, J.
    Lubbeke, A.
    Schwarz, H.
    Rathbun, A.
    Gabay, C.
    Reed, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 403 - 403
  • [25] The impact of biologic agents on cardiovascular risk factors in patients with rheumatoid arthritis: A meta analysis
    Jia, Xiaodong
    Yang, Zheming
    Li, Jiayin
    Mei, Zhu
    Jia, Lihui
    Yan, Chenghui
    PLOS ONE, 2024, 19 (08):
  • [26] POSITIVITY FOR RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE IS ASSOCIATED WITH A BETTER DRUG RETENTION OF ABATACEPT: DATA FROM A PANEUROPEAN ANALYSIS OF RA REGISTRIES
    Gottenberg, J. E.
    Neto, D.
    Gomez-Reino, J.
    Iannone, F.
    Lie, E.
    Canhao, H.
    Pavelka, K.
    Turesson, C.
    Hetland, M.
    Mariette, X.
    Finckh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 502 - 503
  • [27] Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients
    Du Pan, Sophie Martin
    Scherer, Almut
    Gabay, Cem
    Finckh, Axel
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) : 997 - 999
  • [28] Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents
    Miwa, Yusuke
    Hosaka, Michio
    Ohtsuka, Kumiko
    Sato, Michihito
    Takahashi, Ryo
    Wakabayashi, Kuninobu
    Odai, Tsuyoshi
    Yajima, Nobuyuki
    Kasama, Tsuyoshi
    MODERN RHEUMATOLOGY, 2013, 23 (05) : 920 - 924
  • [29] Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs
    Bergman, Gert J. D.
    Hochberg, Marc C.
    Boers, Maarten
    Wintfeld, Neil
    Kielhorn, Adrian
    Jansen, Jeroen P.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (06) : 425 - 441
  • [30] REAL-WORLD INCIDENCE OF BIOLOGIC DOSE ESCALATION AND IMPACT ON BIOLOGIC COSTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH INTRAVENOUS AGENTS ABATACEPT, INFLIXIMAB OR TOCILIZUMAB
    Fowler, R.
    McMorrow, D.
    Smith, D.
    Nadkarni, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 558 - 558
12345